Profile - Ian Cree
Ian Cree
TITLEYvonne Carter Professor of Pathology, Warwick Medical School. Hon. Consultant Pathologist, University Hospitals Coventry and Warwickshire NHS Trust. Senior Clinical Advisor, NIHR Evaluation Trials and Studies Coordinating Centre, EME programme. CONTACT
|
RESEARCH PROFILENew diagnostic technologies are set to deliver better individual outcomes and improved cost effectiveness for the NHS across a wide range of diseases. It is now becoming possible to individualise therapy for disease to a degree that would have been regarded as science fiction a few years ago. This involves the use of many new technologies. WMS is at the forefront of both molecular and imaging solutions that allow the measurement of the changes in tissues and cells that lead to disease. Early diagnosis is often the key to preventing serious consequences for patients, whether one is talking of auto-immune arthritis or cancer. The challenge is now to validate these advances and to develop ways of putting them into practice. |
BACKGROUNDIan Cree is the Yvonne Carter Professor of Pathology at Warwick Medical School, and also a Senior Clinical Advisor to the Efficacy and Mechanism Evaluation (EME) programme for the UK National Institute of Health Research Evaluation Trials and Studies Coordinating Centre, having been its Director from 2008 - 2012. He also chairs the Inter-speciality Committee on Molecular Pathology for the Royal College of Pathologists and sits on the NICE Diagnostics Advisory Committee. Trained as a general pathologist with a PhD in immunology, Ian's research career has been based on investigating disease mechanisms to improve diagnosis and treatment. This has involved him designing, conducting and leading clinical trials as well as a number of large multicentre studies. Ian's current research interests are mostly cancer-related but previous studies have included infectious disease, asthma, and ophthalmology. He has published over 200 papers, and two books. For the last 20 years, Ian has been involved in developing predictive methods to allow individualised therapy of cancer. Ian is has recently been involved in the implementation within pathology departments of mutation testing services, including external quality assurance schemes, and intra-operative assessment of breast cancer sentinel nodes. |
CURRENT RESEARCH PROJECTS
|
SELECTED PUBLICATIONS
|
|
|
| Update My Profile on the Warwick eRA
Portal You can Track My Proposals here |
My Profile last updated: 18/04/2013 |